Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Calcineurin inhibitor vs IV cyclophosphamide

Complete remission · idiopathic steroid‐resistant nephrotic syndrome in children

Calcineurin inhibitor may leads to higher treatment response at 3 to 6 months: complete remission compared with IV cyclophosphamide (low certainty).

1 finding from 1 review

Interventions for idiopathic steroid‐resistant nephrotic syndrome in children 2019 · Cochrane Headline outcomes only
RR 3.43 [1.84, 6.41]
2 studies · 156 participants
Low

Calcineurin inhibitor vs IV cyclophosphamide

Complete or partial remission · idiopathic steroid‐resistant nephrotic syndrome in children

Calcineurin inhibitor may leads to higher treatment response at 3 to 6 months: complete or partial remission compared with IV cyclophosphamide (low certainty).

1 finding from 1 review

Interventions for idiopathic steroid‐resistant nephrotic syndrome in children 2019 · Cochrane Headline outcomes only
RR 1.98 [1.25, 3.13]
2 studies · 156 participants
Low